Effects of a community-based intervention bundle on household transmission of extended spectrum β-lactamase-producing Escherichia coli in rural Burkina Faso to target community-level drivers of antimicrobial resistance in sub-Saharan Africa: a cluster-randomised trial.

Lancet MicrobeAug 6, 2026 (epub)

Raneem Aizouk, Yougbaré Sibidou, Daniel Valia et al.

✦ AI-curated · Sources linked

In 30 seconds

This cluster-randomised controlled trial in rural Burkina Faso evaluated a community-based intervention aimed at reducing household transmission of extended spectrum β-lactamase-producing Escherichia coli (ESBL-E). Among 1203 participants, the intervention did not significantly change ESBL-E acquisition risk in the first six months (HR 1.02), but showed a potential reduction in months 6-9 (HR 0.82).

Key findings

  • At baseline, 57% of control and 49% of intervention group individuals tested positive for ESBL-E.
  • Pre-intervention acquisition incidence rates were 3.8 per 100 person-days in the intervention group.
  • The intervention was associated with a reduction in ESBL-E acquisition risk in months 6-9 (HR 0.82).
  • Acquisition risk was higher in the rainy season (peak HR 1.73) and lower with improved sanitation (HR 0.77).

Why it matters

Understanding the impact of community-level interventions on antimicrobial resistance is crucial for developing effective public health strategies. This study highlights the importance of addressing both antibiotic use and environmental factors in combating ESBL-E transmission.

Source

Published in Lancet Microbe. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.